Randy S. Schrecengost, Ph.D. - Publications

Affiliations: 
2009 University of Virginia, Charlottesville, VA 
Area:
Cell Biology, Microbiology Biology, Oncology

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Schrecengost RS, Keller SN, Schiewer MJ, Knudsen KE, Smith CD. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression. Molecular Cancer Research : McR. PMID 26271487 DOI: 10.1158/1541-7786.Mcr-14-0626  0.92
2014 Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, Sussman RT, Hicks JL, Birbe RC, Draganova-Tacheva RA, Visakorpi T, DeMarzo AM, McMahon SB, Knudsen KE. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression. Cancer Research. 74: 272-86. PMID 24197134 DOI: 10.1158/0008-5472.Can-13-1954  0.92
2014 Schrecengost RS, Augello MA, Knudsen KE. Androgen receptor regulation of prostate cancer progression and metastasis Signaling Pathways and Molecular Mediators in Metastasis. 277-309. DOI: 10.1007/978-94-007-2558-4_12  0.92
2013 Goodwin JF, Schiewer MJ, Dean JL, Schrecengost RS, de Leeuw R, Han S, Ma T, Den RB, Dicker AP, Feng FY, Knudsen KE. A hormone-DNA repair circuit governs the response to genotoxic insult. Cancer Discovery. 3: 1254-71. PMID 24027197 DOI: 10.1158/2159-8290.Cd-13-0108  0.92
2013 Wilson AL, Schrecengost RS, Guerrero MS, Thomas KS, Bouton AH. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. Plos One. 8: e65678. PMID 23762409 DOI: 10.1371/Journal.Pone.0065678  0.92
2013 Wilson AL, Schrecengost RS, Guerrero MS, Thomas KS, Bouton AH. Abstract 3778: Breast Cancer Antiestrogen Resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. Cancer Research. 73: 3778-3778. DOI: 10.1158/1538-7445.Am2013-3778  0.92
2010 Schuh NR, Guerrero MS, Schrecengost RS, Bouton AH. BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling. The Journal of Biological Chemistry. 285: 2309-17. PMID 19940159 DOI: 10.1074/Jbc.M109.046631  0.92
2010 Schrecengost RS, Wilson AL, Guerrero MS, Bouton AH. Abstract 5135: Breast cancer antiestrogen resistance-3 influences breast cancer cell migration by regulating Rac and Rho GTPase signaling Cancer Research. 70: 5135-5135. DOI: 10.1158/1538-7445.Am10-5135  0.92
2008 Deacon DH, Hogan KT, Swanson EM, Chianese-Bullock KA, Denlinger CE, Czarkowski AR, Schrecengost RS, Patterson JW, Teague MW, Slingluff CL. The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines. Bmc Cancer. 8: 360. PMID 19055839 DOI: 10.1186/1471-2407-8-360  0.92
2008 Ta HQ, Thomas KS, Schrecengost RS, Bouton AH. A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Research. 68: 8796-804. PMID 18974122 DOI: 10.1158/0008-5472.Can-08-2426  0.92
2007 Schrecengost RS, Riggins RB, Thomas KS, Guerrero MS, Bouton AH. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Research. 67: 6174-82. PMID 17616674 DOI: 10.1158/0008-5472.Can-06-3455  0.92
2007 Riggins RB, Schrecengost RS, Guerrero MS, Bouton AH. Pathways to tamoxifen resistance. Cancer Letters. 256: 1-24. PMID 17475399 DOI: 10.1016/J.Canlet.2007.03.016  0.92
2005 Cragun WC, Yamshchikov GV, Bissonette EA, Smolkin ME, Eastham S, Petroni GR, Schrecengost RS, Woodson EM, Slingluff CL. Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients. Cancer Immunology, Immunotherapy : Cii. 54: 1095-105. PMID 15889250 DOI: 10.1007/S00262-005-0701-6  0.92
2004 French KJ, Zhuang Y, Schrecengost RS, Copper JE, Xia Z, Smith CD. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1. The Journal of Pharmacology and Experimental Therapeutics. 309: 340-7. PMID 14724220 DOI: 10.1124/Jpet.103.061572  0.92
2003 French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Research. 63: 5962-9. PMID 14522923  0.92
Show low-probability matches.